Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species.
J Med Chem
; 63(13): 7226-7242, 2020 07 09.
Article
in En
| MEDLINE
| ID: mdl-32456431
Full text:
1
Database:
MEDLINE
Main subject:
Factor XIa
/
Fibrinolytic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Year:
2020
Type:
Article